The Use of Topical Hemostatic Agents in Cardiothoracic Surgery

Art Bracey, Aryeh Shander*, Solomon Aronson, Bradley A. Boucher, Domenico Calcaterra, Michael W.A. Chu, Richard Culbertson, Karim Jabr, Henrik Kehlet, Omar Lattouf, S. Chris Malaisrie, C. David Mazer, Martin M. Oberhoffer, Sherri Ozawa, Theolyn Price, Todd Rosengart, Bruce D. Spiess, Giuseppe Turchetti

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

29 Scopus citations


Topical hemostatic agents are used in conjunction with conventional procedures to reduce blood loss. They are often used in cardiothoracic surgery, which is particularly prone to bleeding risks. Variation in their use exists because detailed policy and practice guidelines reflecting the current medical evidence have not been developed to promote best surgical practice in this setting. To address this need, the Society for the Advancement of Blood Management convened an International Hemostatic Expert Panel. This article reviews the available literature and sets out evidence-based recommendations for the use of topical hemostatic agents in cardiothoracic surgery.

Original languageEnglish (US)
Pages (from-to)353-360
Number of pages8
JournalAnnals of Thoracic Surgery
Issue number1
StatePublished - Jul 2017

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'The Use of Topical Hemostatic Agents in Cardiothoracic Surgery'. Together they form a unique fingerprint.

Cite this